{"gene":"DBP","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1990,"finding":"DBP was cloned as a transcriptional activator binding the D site of the albumin promoter; it belongs to the bZIP family (related to Fos, Jun, CREB, C/EBP) but lacks a canonical leucine zipper. DBP protein accumulates only in liver despite mRNA being present in most tissues, establishing that tissue specificity is determined post-transcriptionally. DBP expression is rapidly down-regulated during chemically induced liver regeneration, suggesting a role in hepatocyte proliferation control.","method":"cDNA cloning, Northern and Western blot across multiple rat tissues, liver regeneration model","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — original cloning paper with multiple orthogonal methods, foundational study","pmids":["2331750"],"is_preprint":false},{"year":1990,"finding":"DBP protein accumulates in rat hepatocyte nuclei according to a strict circadian rhythm, reaching maximum around 8 p.m. and falling below detection during morning hours. The oscillation is free-running (circadian, not simply diurnal), is regulated at the transcriptional level, and may be under negative control of glucocorticoid hormones. The albumin gene, a putative DBP target, is transcribed more efficiently in the evening than in the morning, consistent with DBP driving rhythmic albumin transcription.","method":"Western blot of nuclear extracts across time-points, nuclear run-on transcription assay, glucocorticoid treatment experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — direct biochemical measurement of protein oscillation with functional transcriptional readout, foundational paper","pmids":["2261643"],"is_preprint":false},{"year":1991,"finding":"Chicken VBP (vitellogenin gene-binding protein) is the avian ortholog of rat DBP; both are bZIP proteins that dimerize and bind DNA as dimers. Despite only three amino acid differences in their basic/hinge regions, DBP's albumin D-site is a poor binding site for VBP, indicating distinct optimal DNA-binding sites. Their leucine zippers are functionally compatible (forming heterodimers) but define a novel bZIP subfamily.","method":"cDNA expression library screening, DNA-binding assays, dimerization studies, sequence comparison","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and dimerization assays; single lab","pmids":["1922023"],"is_preprint":false},{"year":1992,"finding":"DBP directly binds to and transactivates the CYP2C6 promoter in hepatoma cells through a sequence between -38 and -103 bp upstream of the transcription start site. DNase I footprinting with partially purified DBP confirmed a specific footprint at -43 to -64 bp. Gel-shift/Western immunoblot showed DBP binding is age-dependent, appearing only after 3 weeks of age in rats and reaching maximum by 7 weeks, paralleling the postnatal rise in CYP2C6 expression.","method":"Transient transfection in HepG2 cells, DNase I footprinting, gel mobility shift assay, Western immunoblot","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical methods (footprinting, EMSA, transfection) in single study","pmids":["1588973"],"is_preprint":false},{"year":1992,"finding":"DBP, along with HNF-1α and LAP/C/EBP, regulates the liver-restricted promoter of the alpha-2,6-sialyltransferase gene. Footprinting and deletion analysis identified a consensus DBP/LAP binding cis-element essential for liver-specific expression; expression vectors encoding DBP trans-activated the sialyltransferase promoter in cotransfection assays, demonstrating that tissue-specific glycosylation can be regulated transcriptionally by the same liver-enriched factors controlling other liver-specific genes.","method":"DNase I footprinting, 5' deletion analysis, site-directed mutagenesis, cotransfection assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 — multiple methods; single lab","pmids":["1737800"],"is_preprint":false},{"year":1993,"finding":"DBP directly activates the cholesterol 7α-hydroxylase (C7αH) gene promoter through a cognate DNA site at approximately -225 bp, as shown by cotransfection assays. In nuclear extracts prepared by a novel method recovering near-quantitative DBP, the predominant binding activity at this promoter site in the evening (when DBP is high) was shown to contain DBP by supershift, providing direct evidence that DBP drives the circadian expression of C7αH, the rate-limiting enzyme in bile acid synthesis.","method":"Cotransfection assays, novel nuclear extract preparation, DNase I footprinting, gel shift/supershift assay","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods with direct in vivo occupancy evidence, replicated by genetic studies","pmids":["8405996"],"is_preprint":false},{"year":1993,"finding":"DBP synergizes with C/EBP to compensate for the haemophilia B Leyden factor IX -5 mutation. The -5 nucleotide substitution disrupts binding of proteins to one of three newly identified transcription factor binding sites in the factor IX promoter. Post-pubertal induction of DBP (which is induced at puberty) allows DBP and C/EBP to synergistically restore transcriptional activity of the mutant -5 promoter, explaining the clinical recovery seen after puberty in Leyden patients.","method":"Transcription factor binding site characterization, gel-shift assays, cotransfection/transactivation assays","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical and functional evidence; single lab with clear mechanistic model","pmids":["8499951"],"is_preprint":false},{"year":1994,"finding":"Human DBP gene was cloned and chromosomally localized to 19q13; human TEF to 22q13. The coding sequences, particularly the bZIP domain and PAR region, are highly conserved between human and rat DBP. Conservation of exon-intron boundaries around the bZIP-encoding exon suggests derivation from a common ancestral gene shared with TEF and HLF. DBP mRNA was detected in all tissues examined (brain, lung, liver, spleen, kidney), consistent with broad but rhythmically controlled expression.","method":"cDNA cloning, FISH chromosomal mapping, somatic cell hybrid analysis, Northern blot","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct cloning and chromosomal mapping; single lab","pmids":["7835883"],"is_preprint":false},{"year":1997,"finding":"DBP mRNA oscillates strongly in the suprachiasmatic nucleus (SCN) of the hypothalamus, with peak levels ~4 hours earlier than in liver, indicating tissue-specific control of circadian DBP expression. Dbp-null mice display reduced locomotor activity and a shorter free-running circadian period, establishing DBP as a modulator of circadian behavioral outputs. Since DBP-/- mice remain rhythmic and DBP is not required for circadian expression of its own gene, DBP functions in the circadian output pathway rather than as a core clock component.","method":"In situ hybridization in SCN, generation and analysis of Dbp-null mice (locomotor activity, free-running period)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with defined behavioral phenotype, replicated subsequently","pmids":["9362490"],"is_preprint":false},{"year":1999,"finding":"DBP drives circadian expression of the Cyp2a4 (steroid 15α-hydroxylase) and Cyp2a5 (coumarin 7-hydroxylase) genes in mouse liver. In vitro DNase I footprinting on Cyp2a4 and Cyp2a5 promoters and cotransfection in HepG2 cells confirmed DBP can activate these promoters. Genetic validation using Dbp-null mice showed significantly impaired circadian amplitude of CYP2A4 and CYP2A5 mRNA and protein, establishing DBP as a major factor controlling their rhythmic hepatic expression.","method":"DNase I footprinting, cotransfection assays, Dbp-null mouse experiments (mRNA and protein quantification)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical and genetic evidence combined, multiple methods","pmids":["10490589"],"is_preprint":false},{"year":2000,"finding":"DBP activates the mPer1 promoter by directly binding to it, and this activation is cooperative with CLOCK-BMAL1. Dbp transcription is itself activated by CLOCK-BMAL1 through E-boxes and repressed by mPER and mCRY proteins, placing DBP within the core circadian feedback loop as both a target and an amplifier of CLOCK-BMAL1 activity acting on Per1.","method":"Reporter gene assays (cotransfection), direct promoter binding assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding and functional reporter assays; single lab","pmids":["10848603"],"is_preprint":false},{"year":2000,"finding":"Loss of DBP (Dbp-/- mice) reduces the amplitude of circadian modulation of sleep time and sleep episode consolidation under both light-dark and constant-dark conditions without affecting total sleep duration. DBP deficiency also reduces amplitude of sleep-wake-dependent changes in slow-wave sleep delta power, increases hippocampal theta peak frequency, and abolishes the paradoxical sleep rebound after sleep deprivation, establishing DBP as a transcriptional regulator of both circadian and homeostatic aspects of sleep.","method":"EEG/EMG recordings in Dbp-/- mice, sleep deprivation experiments, quantitative EEG analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with specific quantitative phenotypic readouts across multiple sleep parameters","pmids":["10632591"],"is_preprint":false},{"year":2000,"finding":"CLOCK is required for circadian Dbp transcription. Genetic experiments with Clock-mutant mice and biochemical studies demonstrated that CLOCK binds to E-box motifs within putative enhancer regions in the first and second introns of the Dbp gene to drive its rhythmic expression. The same E-box mechanism that controls core clock gene mPeriod1 expression also directly controls the rhythmic transcription of the clock output regulator Dbp.","method":"Analysis of Clock-mutant mice (Dbp mRNA levels), electrophoretic mobility shift assays, reporter gene assays with E-box mutants","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — genetic and biochemical evidence combined, replicated by later chromatin studies","pmids":["10733528"],"is_preprint":false},{"year":2004,"finding":"DEC2 (but not DEC1) suppresses DBP-mediated transcriptional activation of the cholesterol 7α-hydroxylase (CYP7A) gene by binding to an E-box (CACATG) at -219/-214 of CYP7A, overwhelming DBP's potent enhancement. This establishes a mechanistic antagonism where the clock-controlled repressor DEC2 opposes the clock-controlled activator DBP to regulate rhythmic cytochrome P450 expression in the liver.","method":"Transfection reporter assays, electrophoretic mobility shift assays (EMSA)","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 — direct EMSA and functional reporter assays defining antagonism; single lab","pmids":["15066123"],"is_preprint":false},{"year":2005,"finding":"Hippocampal over-expression of DBP (via rAAV) in adult rats upregulates molecular clock constituents and the DBP target gene pyridoxal kinase. DBP over-expression inhibits spatial learning (but not memory), enhances susceptibility to kainate-induced seizures, and activates MAP kinase in dendritic regions of hippocampal neurons in vivo, establishing DBP as a transcriptional link between GLP-1R activation and hippocampal neuroplasticity.","method":"rAAV-mediated gene delivery, microarray analysis, behavioral testing (water maze), kainate seizure model, in vivo MAP kinase immunostaining","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gain-of-function with defined behavioral and molecular phenotypes; single lab","pmids":["16257226"],"is_preprint":false},{"year":2006,"finding":"Circadian Dbp transcription is driven by rhythmic binding of BMAL1 and CLOCK to multiple extra- and intragenic E-box motifs. This binding is accompanied by marked daily chromatin transitions: the transcriptionally active phase shows acetylation of H3K9, trimethylation of H3K4, and reduced histone density, while the repressive phase shows dimethylation of H3K9, binding of heterochromatin protein 1α (HP1α), and increased histone density. The rhythmic conversion between permissive chromatin and facultative heterochromatin requires functional BMAL1-CLOCK binding sites.","method":"ChIP assays (BMAL1, CLOCK, histone modifications, HP1α) across circadian time-points, E-box mutant analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — comprehensive ChIP-based chromatin analysis across multiple marks, strong mechanistic detail, highly cited","pmids":["16474407"],"is_preprint":false},{"year":2006,"finding":"PAR bZIP proteins DBP, TEF, and HLF control expression of many enzymes involved in xenobiotic detoxification and drug metabolism in liver and kidney, including cytochrome P450 enzymes, carboxylesterases, and constitutive androstane receptor (CAR). Triple knockout mice (Dbp/Tef/Hlf -/-) are hypersensitive to xenobiotic compounds, and the deficiency in detoxification contributes to their early aging and premature death phenotype.","method":"Triple knockout mouse generation and analysis, liver/kidney transcriptome comparison, xenobiotic challenge experiments","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with transcriptome and physiological phenotype, multiple orthogonal approaches","pmids":["16814730"],"is_preprint":false},{"year":2010,"finding":"Triple PAR bZIP knockout mice (Dbp/Tef/Hlf -/-) develop cardiac hypertrophy and left ventricular dysfunction associated with low blood pressure and abnormally low aldosterone levels, demonstrating that PAR bZIP transcription factors (including DBP) are required for normal circadian regulation of cardiovascular function.","method":"Echocardiography, blood pressure measurement, aldosterone assays in triple PAR bZIP knockout mice","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with defined cardiovascular phenotypes; attribution shared among three PAR bZIPs","pmids":["20686175"],"is_preprint":false},{"year":2011,"finding":"Cell-autonomous siRNA knockdown of DBP in Rat-1 fibroblasts produces a short-period circadian phenotype, while DBP overexpression produces a long-period rhythm in Per1 and Per2 promoter-driven bioluminescence reporters. Conversely, knockdown/overexpression of E4BP4 (the D-box repressor) has the opposite effect. This establishes that DBP (D-box activator) and E4BP4 (D-box repressor) are critical cell-autonomous determinants of circadian period length.","method":"siRNA knockdown, cDNA overexpression, bioluminescent circadian reporter assays in Rat-1 fibroblasts","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — cell-autonomous genetic perturbation with quantitative circadian readout; single lab","pmids":["21635892"],"is_preprint":false},{"year":2011,"finding":"DBP binds to a D-box element in the Kiss1 promoter in the anteroventral periventricular nucleus (AVPV) and triggers Kiss1 transcription; this effect is synergistic with estrogen receptor α (ERα) and estrogen. Dbp mRNA accumulates with a robust diurnal rhythm in the AVPV specifically on proestrus (but not diestrus), and some AVPV cells co-express DBP and ERα. This establishes DBP as a circadian transcriptional regulator linking the clock to the GnRH/LH surge through Kiss1.","method":"Reporter gene/cotransfection assays with D-box mutations, in situ hybridization, immunohistochemistry of AVPV","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding assay combined with anatomical co-expression data; single lab","pmids":["21458520"],"is_preprint":false},{"year":2012,"finding":"BMAL1-CLOCK associations with Dbp chromatin are extremely unstable, showing stochastic, proteasome-dependent fluctuations monitored in real time by fluorescent BMAL1 at tandem Dbp repeat arrays. Proteasome inhibition prolongs BMAL1-CLOCK residence time but immediately attenuates Dbp transcription by decreasing both the frequency and size of transcriptional bursts. This reveals that BMAL1 and CLOCK act as 'Kamikaze activators' that must be rapidly degraded after binding to sustain transcriptional cycling.","method":"Live-cell fluorescence time-lapse microscopy of BMAL1-GFP at Dbp locus arrays, proteasome inhibition, single-copy Dbp-luciferase reporter analysis of transcriptional bursting","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstitution-level live imaging with pharmacological perturbation and single-gene reporter, multiple orthogonal approaches in one study","pmids":["22981862"],"is_preprint":false},{"year":2016,"finding":"PI3K signaling is required for BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter. Pharmacological inhibition or shRNA knockdown of PI3K blocked serum-shock-induced upregulation of Dbp mRNA and reduced Dbp promoter activity. PI3K inhibition decreased recruitment of BMAL1/CLOCK to the E-box in the Dbp promoter and blocked BMAL1-CLOCK heterodimerization, establishing PI3K as an upstream modulator of the circadian transcriptional complex at Dbp.","method":"Pharmacological PI3K inhibition, shRNA knockdown, RT-PCR, luciferase reporter assays, ChIP assay (BMAL1 at E-box), co-immunoprecipitation of BMAL1-CLOCK","journal":"Bioscience, biotechnology, and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (ChIP, co-IP, reporter, KD) in single study; single lab","pmids":["27022680"],"is_preprint":false}],"current_model":"DBP is a PAR-domain bZIP transcription factor that accumulates in a strict circadian rhythm (driven by CLOCK-BMAL1 binding to intronic E-boxes with accompanying chromatin transitions from permissive to facultative heterochromatin) and functions as a clock output regulator by directly binding D-box elements to activate target genes involved in cholesterol/bile acid metabolism (CYP7A1), drug detoxification (CYP2A4, CYP2A5, CYP2C6, xenobiotic enzymes), and neuroendocrine control (Kiss1, mPer1); loss of DBP shortens circadian period, reduces locomotor activity amplitude, disrupts sleep consolidation and EEG rhythms, and—together with the other PAR bZIP factors TEF and HLF—causes hypersensitivity to xenobiotics and cardiovascular dysfunction, while BMAL1-CLOCK drive Dbp transcription through a 'Kamikaze activator' mechanism requiring rapid proteasomal degradation of the transcriptional complex to sustain transcriptional bursting."},"narrative":{"teleology":[{"year":1990,"claim":"Identification of DBP as a liver-enriched bZIP transcription factor with strict circadian protein accumulation established the first known mammalian transcriptional activator whose abundance oscillates with a free-running circadian rhythm.","evidence":"cDNA cloning from rat liver, Western blots across tissues and circadian time-points, nuclear run-on transcription assays","pmids":["2331750","2261643"],"confidence":"High","gaps":["Mechanism driving circadian mRNA/protein oscillation unknown","In vivo target genes beyond albumin not identified","Post-transcriptional mechanism restricting protein to liver not defined"]},{"year":1992,"claim":"Demonstration that DBP directly binds and transactivates hepatic cytochrome P450 (CYP2C6) and sialyltransferase promoters extended DBP's role from albumin regulation to liver-specific drug metabolism and glycosylation programs.","evidence":"DNase I footprinting, EMSA, cotransfection reporter assays in HepG2 cells","pmids":["1588973","1737800"],"confidence":"High","gaps":["No loss-of-function evidence yet linking DBP to CYP2C6 expression in vivo","Relative contributions of DBP versus other liver-enriched factors (C/EBP, HNF) not delineated"]},{"year":1993,"claim":"Identification of DBP as a direct activator of cholesterol 7α-hydroxylase (CYP7A1) connected the circadian DBP oscillation to a rate-limiting metabolic step—bile acid synthesis—providing the first functional link between circadian clock output and intermediary metabolism.","evidence":"Cotransfection assays, supershift of evening nuclear extracts confirming DBP occupancy at CYP7A1 promoter","pmids":["8405996"],"confidence":"High","gaps":["No genetic validation in Dbp-null animals for CYP7A1 regulation","Contribution of other D-box activators (TEF, HLF) not assessed"]},{"year":1993,"claim":"Evidence that DBP synergizes with C/EBP to restore factor IX transcription from the Leyden -5 mutant promoter after puberty explained the clinical recovery in haemophilia B Leyden by invoking pubertal DBP induction.","evidence":"Gel-shift assays and cotransfection transactivation assays with mutant factor IX promoter","pmids":["8499951"],"confidence":"Medium","gaps":["Mechanism of pubertal DBP induction not defined","In vivo confirmation in patient-derived cells lacking","Relative importance of DBP versus androgen-responsive factors not resolved"]},{"year":1997,"claim":"Generation of Dbp-null mice established that DBP is dispensable for core clock function but required for normal circadian period length and locomotor activity amplitude, positioning DBP as a clock output regulator rather than a core oscillator component.","evidence":"Dbp-knockout mice, locomotor activity recording under constant darkness, in situ hybridization in SCN","pmids":["9362490"],"confidence":"High","gaps":["Molecular targets responsible for shortened period not identified","Redundancy with TEF/HLF not tested genetically"]},{"year":2000,"claim":"Phenotyping of Dbp-null mice for sleep architecture revealed that DBP regulates circadian modulation of sleep consolidation, EEG delta power, theta frequency, and paradoxical sleep rebound, establishing DBP as a transcriptional link between the clock and sleep homeostasis.","evidence":"EEG/EMG recordings in Dbp−/− mice under LD and DD, sleep deprivation and recovery protocols","pmids":["10632591"],"confidence":"High","gaps":["Downstream transcriptional targets mediating sleep phenotypes unknown","Brain region-specific versus systemic DBP contributions not dissected"]},{"year":2000,"claim":"Discovery that CLOCK binds E-box elements in Dbp introns and that Clock mutation abolishes rhythmic Dbp transcription defined the upstream molecular mechanism placing Dbp as a direct first-order target of the CLOCK–BMAL1 heterodimer, while DBP feeds forward onto Per1 cooperatively with CLOCK–BMAL1.","evidence":"Clock-mutant mouse Dbp mRNA analysis, EMSA with E-box probes, Per1 promoter cotransfection assays","pmids":["10733528","10848603"],"confidence":"High","gaps":["Chromatin context of E-box activation not characterized","Quantitative contribution of DBP to Per1 amplitude versus direct CLOCK–BMAL1 drive unclear"]},{"year":2006,"claim":"Comprehensive ChIP analysis revealed that BMAL1–CLOCK binding at Dbp E-boxes drives daily chromatin transitions between permissive euchromatin (H3K9ac, H3K4me3) and repressive heterochromatin (H3K9me2, HP1α), providing the first genome-locus-specific model of how circadian transcription factors remodel chromatin.","evidence":"Time-resolved ChIP for BMAL1, CLOCK, H3K9ac, H3K4me3, H3K9me2, HP1α at Dbp locus; E-box mutant reporter analysis","pmids":["16474407"],"confidence":"High","gaps":["Identity of histone methyltransferases/demethylases mediating these transitions unknown","Whether similar chromatin cycling occurs at all CLOCK–BMAL1 targets not established"]},{"year":2006,"claim":"Triple PAR bZIP knockout (Dbp/Tef/Hlf−/−) demonstrated that these factors collectively govern xenobiotic detoxification gene programs, with compound loss causing xenobiotic hypersensitivity, premature aging, and death—resolving the long-standing question of functional redundancy among PAR bZIP members.","evidence":"Triple-KO mouse generation, transcriptome profiling of liver/kidney, xenobiotic challenge survival experiments","pmids":["16814730"],"confidence":"High","gaps":["Individual contributions of DBP, TEF, and HLF not separable in triple-KO","Non-hepatic detoxification roles not examined"]},{"year":2011,"claim":"Cell-autonomous gain- and loss-of-function experiments showed DBP and its D-box antagonist E4BP4 are critical determinants of circadian period at the single-cell level, and identification of Kiss1 as a direct DBP target in the AVPV linked the circadian clock to the preovulatory GnRH/LH surge.","evidence":"siRNA/overexpression of DBP in Rat-1 fibroblasts with bioluminescent reporters; Kiss1 promoter D-box reporter assays and AVPV in situ hybridization","pmids":["21635892","21458520"],"confidence":"Medium","gaps":["In vivo reproductive phenotype of Dbp-null females not reported","Whether DBP's period-setting role depends on its transcriptional targets or direct protein interactions unknown"]},{"year":2012,"claim":"Live-cell imaging of BMAL1 at Dbp locus arrays revealed that BMAL1–CLOCK act as 'Kamikaze activators' requiring proteasome-dependent rapid turnover to sustain transcriptional bursting, fundamentally revising the model of how circadian transcription factors activate target genes.","evidence":"Fluorescent BMAL1 live imaging at tandem Dbp repeat arrays, proteasome inhibition (MG132), single-copy Dbp-luciferase burst analysis","pmids":["22981862"],"confidence":"High","gaps":["Ubiquitin ligase(s) targeting BMAL1–CLOCK at Dbp not identified","Whether Kamikaze mechanism generalizes to all circadian target promoters not tested","Relationship between burst frequency and chromatin state transitions unexplored"]},{"year":null,"claim":"Outstanding questions include the identity of the E3 ligase(s) that mediate BMAL1–CLOCK turnover at the Dbp locus, the brain region–specific transcriptional targets through which DBP controls sleep architecture and seizure susceptibility, and the individual versus redundant contributions of DBP relative to TEF and HLF at specific promoters in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of DBP–D-box DNA complex available","Post-transcriptional mechanisms restricting DBP protein to specific tissues not characterized","Genome-wide direct target map (ChIP-seq for DBP) in vivo not published in the timeline"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3,5,9,10,19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,5,9,10,16,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,15]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,5,10,15,20]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,9,13,16]}],"complexes":[],"partners":["ARNTL","CLOCK","TEF","HLF","NFIL3","ESR1"],"other_free_text":[]},"mechanistic_narrative":"DBP is a PAR-domain basic leucine zipper (bZIP) transcription factor that functions as a principal circadian clock output regulator, linking the core CLOCK–BMAL1 oscillator to rhythmic gene expression in liver, brain, and neuroendocrine tissues. CLOCK–BMAL1 drives Dbp transcription through intronic and extragenic E-box elements accompanied by circadian chromatin remodeling between permissive (H3K9ac, H3K4me3) and facultative heterochromatin (H3K9me2, HP1α) states, with sustained transcriptional bursting dependent on rapid proteasomal turnover of the BMAL1–CLOCK complex [PMID:16474407, PMID:22981862]. DBP protein accumulates with a high-amplitude circadian rhythm and directly activates D-box-containing promoters of genes governing cholesterol/bile acid metabolism (CYP7A1), xenobiotic detoxification (CYP2A4/5, CYP2C6, CAR), the core clock (mPer1), and reproductive neuroendocrine signaling (Kiss1), functioning redundantly with the PAR bZIP factors TEF and HLF [PMID:8405996, PMID:10490589, PMID:16814730, PMID:21458520]. Dbp-null mice exhibit a shortened free-running circadian period, reduced locomotor activity amplitude, disrupted sleep consolidation, and impaired EEG slow-wave and theta rhythms, while compound loss of all three PAR bZIPs causes xenobiotic hypersensitivity, premature aging, and cardiovascular dysfunction [PMID:9362490, PMID:10632591, PMID:16814730, PMID:20686175]."},"prefetch_data":{"uniprot":{"accession":"Q10586","full_name":"D site-binding protein","aliases":["Albumin D box-binding protein","Albumin D-element-binding protein","Tax-responsive enhancer element-binding protein 302","TaxREB302"],"length_aa":325,"mass_kda":34.3,"function":"This transcriptional activator recognizes and binds to the sequence 5'-RTTAYGTAAY-3' found in the promoter of genes such as albumin, CYP2A4 and CYP2A5. It is not essential for circadian rhythm generation, but modulates important clock output genes. May be a direct target for regulation by the circadian pacemaker component clock. May affect circadian period and sleep regulation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q10586/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DBP","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DBP","total_profiled":1310},"omim":[{"mim_id":"611421","title":"SNF2-RELATED CBP ACTIVATOR PROTEIN; SRCAP","url":"https://www.omim.org/entry/611421"},{"mim_id":"610262","title":"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6","url":"https://www.omim.org/entry/610262"},{"mim_id":"608622","title":"HYPERTENSION, DIASTOLIC, RESISTANCE TO","url":"https://www.omim.org/entry/608622"},{"mim_id":"607510","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16; ADAMTS16","url":"https://www.omim.org/entry/607510"},{"mim_id":"607037","title":"ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH","url":"https://www.omim.org/entry/607037"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DBP"},"hgnc":{"alias_symbol":["DABP"],"prev_symbol":[]},"alphafold":{"accession":"Q10586","domains":[{"cath_id":"-","chopping":"202-237_255-299","consensus_level":"medium","plddt":94.6285,"start":202,"end":299}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q10586","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q10586-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q10586-F1-predicted_aligned_error_v6.png","plddt_mean":68.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DBP","jax_strain_url":"https://www.jax.org/strain/search?query=DBP"},"sequence":{"accession":"Q10586","fasta_url":"https://rest.uniprot.org/uniprotkb/Q10586.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q10586/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q10586"}},"corpus_meta":[{"pmid":"23359474","id":"PMC_23359474","title":"Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23359474","citation_count":609,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16474407","id":"PMC_16474407","title":"Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions.","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16474407","citation_count":467,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16814730","id":"PMC_16814730","title":"The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification.","date":"2006","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16814730","citation_count":400,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2331750","id":"PMC_2331750","title":"DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2331750","citation_count":385,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10733528","id":"PMC_10733528","title":"CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP.","date":"2000","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10733528","citation_count":343,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24095930","id":"PMC_24095930","title":"Vitamin D and DBP: the free hormone hypothesis revisited.","date":"2013","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24095930","citation_count":322,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8405996","id":"PMC_8405996","title":"Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8405996","citation_count":275,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9362490","id":"PMC_9362490","title":"The DBP gene is expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences circadian behavior.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9362490","citation_count":238,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2261643","id":"PMC_2261643","title":"Expression of the liver-enriched transcriptional activator protein DBP follows a stringent circadian rhythm.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2261643","citation_count":212,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10848603","id":"PMC_10848603","title":"Role of DBP in the circadian oscillatory mechanism.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10848603","citation_count":203,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20673864","id":"PMC_20673864","title":"Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20673864","citation_count":199,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24885631","id":"PMC_24885631","title":"25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24885631","citation_count":191,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10490589","id":"PMC_10490589","title":"Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10490589","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21743458","id":"PMC_21743458","title":"Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21743458","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12659668","id":"PMC_12659668","title":"Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.","date":"2003","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12659668","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10632591","id":"PMC_10632591","title":"The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10632591","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33120154","id":"PMC_33120154","title":"Effect of polystyrene on di-butyl phthalate (DBP) bioavailability and DBP-induced phytotoxicity in lettuce.","date":"2020","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/33120154","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22981862","id":"PMC_22981862","title":"Circadian Dbp transcription relies on highly dynamic BMAL1-CLOCK interaction with E boxes and requires the proteasome.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22981862","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24415938","id":"PMC_24415938","title":"Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/24415938","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1922023","id":"PMC_1922023","title":"Chicken vitellogenin gene-binding protein, a leucine zipper transcription factor that binds to an important control element in the chicken vitellogenin II promoter, is related to rat DBP.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1922023","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1737800","id":"PMC_1737800","title":"Regulated expression of alpha 2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1737800","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29112835","id":"PMC_29112835","title":"Biodegradation of di-n-butyl phthalate (DBP) by a novel endophytic Bacillus megaterium strain YJB3.","date":"2017","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/29112835","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15458795","id":"PMC_15458795","title":"Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone.","date":"2004","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/15458795","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15513902","id":"PMC_15513902","title":"Neonatal exposure to di(n-butyl) phthalate (DBP) alters male reproductive-tract development.","date":"2004","source":"Journal of toxicology and environmental health. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/15513902","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28578144","id":"PMC_28578144","title":"Role of PI3K/AKT/mTOR signaling pathway in DBP-induced apoptosis of testicular sertoli cells in vitro.","date":"2017","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28578144","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25765776","id":"PMC_25765776","title":"Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice.","date":"2015","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25765776","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15066123","id":"PMC_15066123","title":"Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15066123","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21635892","id":"PMC_21635892","title":"Cellular DBP and E4BP4 proteins are critical for determining the period length of the circadian oscillator.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21635892","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20686175","id":"PMC_20686175","title":"Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF.","date":"2010","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20686175","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33162130","id":"PMC_33162130","title":"Complete biodegradation of di-n-butyl phthalate (DBP) by a novel Pseudomonas sp. YJB6.","date":"2020","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/33162130","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30469006","id":"PMC_30469006","title":"Exposure to DBP induces the toxicity in early development and adverse effects on cardiac development in zebrafish (Danio rerio).","date":"2018","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/30469006","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32770768","id":"PMC_32770768","title":"The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate.","date":"2020","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/32770768","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25350643","id":"PMC_25350643","title":"The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study.","date":"2014","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25350643","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8499951","id":"PMC_8499951","title":"Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8499951","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31133752","id":"PMC_31133752","title":"Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.","date":"2019","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31133752","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28913550","id":"PMC_28913550","title":"Oxidative Damage and Genetic Toxicity Induced by DBP in Earthworms (Eisenia fetida).","date":"2017","source":"Archives of environmental contamination and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28913550","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18807170","id":"PMC_18807170","title":"Alteration of DBP levels in CSF of patients with MS by proteomics analysis.","date":"2008","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18807170","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10643655","id":"PMC_10643655","title":"Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin.","date":"1999","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10643655","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24056307","id":"PMC_24056307","title":"Short-term neonatal/prepubertal exposure of dibutyl phthalate (DBP) advanced pubertal timing and affected hypothalamic kisspeptin/GPR54 expression differently in female rats.","date":"2013","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/24056307","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37418586","id":"PMC_37418586","title":"Unravelling High-Molecular-Weight DBP Toxicity Drivers in Chlorinated and Chloraminated Drinking Water: Effect-Directed Analysis of Molecular Weight Fractions.","date":"2023","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/37418586","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31387634","id":"PMC_31387634","title":"Role of JNK and ERK1/2 MAPK signaling pathway in testicular injury of rats induced by di-N-butyl-phthalate (DBP).","date":"2019","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/31387634","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1588973","id":"PMC_1588973","title":"Role of the liver-enriched transcription factor DBP in expression of the cytochrome P450 CYP2C6 gene.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1588973","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19549552","id":"PMC_19549552","title":"Long-term effects of developmental exposure to di-n-butyl-phthalate (DBP) on rat prostate: proliferative and inflammatory disorders and a possible role of androgens.","date":"2009","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/19549552","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25541958","id":"PMC_25541958","title":"Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25541958","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21153172","id":"PMC_21153172","title":"Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP).","date":"1995","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/21153172","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30025259","id":"PMC_30025259","title":"Biodegradation of di-butyl phthalate (DBP) by a novel endophytic bacterium Bacillus subtilis and its bioaugmentation for removing DBP from vegetation slurry.","date":"2018","source":"Journal of environmental management","url":"https://pubmed.ncbi.nlm.nih.gov/30025259","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32075983","id":"PMC_32075983","title":"Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32075983","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28415704","id":"PMC_28415704","title":"Maternal exposure to di-n-butyl phthalate (DBP) induces renal fibrosis in adult rat offspring.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28415704","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30391722","id":"PMC_30391722","title":"Effects of two environmental endocrine disruptors di-n-butyl phthalate (DBP) and mono-n-butyl phthalate (MBP) on human sperm functions in vitro.","date":"2018","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30391722","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25793371","id":"PMC_25793371","title":"Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design.","date":"2015","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25793371","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1883358","id":"PMC_1883358","title":"SF-B that binds to a negative element in glutathione transferase P gene is similar or identical to trans-activator LAP/IL6-DBP.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1883358","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29385629","id":"PMC_29385629","title":"Exposure to DBP and High Iodine Aggravates Autoimmune Thyroid Disease Through Increasing the Levels of IL-17 and Thyroid-Binding Globulin in Wistar Rats.","date":"2018","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29385629","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28467950","id":"PMC_28467950","title":"The shadow of dichloroacetonitrile (DCAN), a typical nitrogenous disinfection by-product (N-DBP), in the waterworks and its backwash water reuse.","date":"2017","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/28467950","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21544203","id":"PMC_21544203","title":"Thyroid disruption by Di-n-butyl phthalate (DBP) and mono-n-butyl phthalate (MBP) in Xenopus laevis.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21544203","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16257226","id":"PMC_16257226","title":"A novel role of circadian transcription factor DBP in hippocampal plasticity.","date":"2005","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/16257226","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19464577","id":"PMC_19464577","title":"Molecular and toxicologic research in newborn hypospadiac male rats following in utero exposure to di-n-butyl phthalate (DBP).","date":"2009","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/19464577","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32498213","id":"PMC_32498213","title":"Characteristics of low and high SUVA precursors: Relationships among molecular weight, fluorescence, and chemical composition with DBP formation.","date":"2020","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/32498213","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29414342","id":"PMC_29414342","title":"DEP and DBP induce cytotoxicity in mouse embryonic stem cells and abnormally enhance neural ectoderm development.","date":"2018","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/29414342","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27079746","id":"PMC_27079746","title":"Maternal exposure to di-n-butyl phthalate (DBP) induces combined anorectal and urogenital malformations in male rat offspring.","date":"2016","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/27079746","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23548751","id":"PMC_23548751","title":"Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study.","date":"2013","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23548751","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7835883","id":"PMC_7835883","title":"Chromosomal localization and cDNA cloning of the human DBP and TEF genes.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7835883","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2673244","id":"PMC_2673244","title":"Fatty acids bound to vitamin D-binding protein (DBP) from human and bovine sera.","date":"1989","source":"Biochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/2673244","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31404886","id":"PMC_31404886","title":"The role of ANXA5 in DBP-induced oxidative stress through ERK/Nrf2 pathway.","date":"2019","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31404886","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11255236","id":"PMC_11255236","title":"Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity.","date":"2001","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11255236","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16400520","id":"PMC_16400520","title":"Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.","date":"2006","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16400520","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26608873","id":"PMC_26608873","title":"Physiological differences in response to di-n-butyl phthalate (DBP) exposure between low- and high-DBP accumulating cultivars of Chinese flowering cabbage (Brassica parachinensis L.).","date":"2015","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/26608873","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31260805","id":"PMC_31260805","title":"Use of the Adverse Outcome Pathway (AOP) framework to evaluate species concordance and human relevance of Dibutyl phthalate (DBP)-induced male reproductive toxicity.","date":"2019","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31260805","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28919491","id":"PMC_28919491","title":"Potential involvement of Fgf10/Fgfr2 and androgen receptor (AR) in renal fibrosis in adult male rat offspring subjected to prenatal exposure to di-n-butyl phthalate (DBP).","date":"2017","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28919491","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22150342","id":"PMC_22150342","title":"The endocrine disruptors dibutyl phthalate (DBP) and diethylstilbestrol (DES) influence Leydig cell regeneration following ethane dimethane sulphonate treatment of adult male rats.","date":"2011","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/22150342","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19585553","id":"PMC_19585553","title":"Reproductive toxicity and pharmacokinetics of di-n-butyl phthalate (DBP) following dietary exposure of pregnant rats.","date":"2009","source":"Birth defects research. Part B, Developmental and reproductive toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/19585553","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24983780","id":"PMC_24983780","title":"The effects on steroidogenesis and histopathology of adult male Japanese quails (Coturnix coturnix japonica) testis following pre-pubertal exposure to di(n-butyl) phthalate (DBP).","date":"2014","source":"Comparative biochemistry and physiology. Toxicology & pharmacology : CBP","url":"https://pubmed.ncbi.nlm.nih.gov/24983780","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37677100","id":"PMC_37677100","title":"Are New Phthalate Ester Substitutes Safer than Traditional DBP and DiBP? Comparative Endocrine-Disrupting Analyses on Zebrafish Using In Vivo, Transcriptome, and In Silico Approaches.","date":"2023","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/37677100","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37977363","id":"PMC_37977363","title":"DEHP and DBP, common phthalates, induce glucose metabolism disorders in rats via oxidative damage of PI3K/Akt/GLUT4 signaling.","date":"2023","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/37977363","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26065888","id":"PMC_26065888","title":"Toxicity and molecular effects of di-n-butyl phthalate (DBP) on CYP1A, SOD, and GPx in Cyprinus carpio (common carp).","date":"2015","source":"Environmental monitoring and assessment","url":"https://pubmed.ncbi.nlm.nih.gov/26065888","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26948521","id":"PMC_26948521","title":"Prenatal exposure to di-n-butyl phthalate (DBP) differentially alters androgen cascade in undeformed versus hypospadiac male rat offspring.","date":"2016","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26948521","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32810643","id":"PMC_32810643","title":"Maternal exposure to Di-n-butyl phthalate (DBP) aggravate gestational diabetes mellitus via FoxM1 suppression by pSTAT1 signalling.","date":"2020","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/32810643","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35955852","id":"PMC_35955852","title":"Adult Exposure to Di-N-Butyl Phthalate (DBP) Induces Persistent Effects on Testicular Cell Markers and Testosterone Biosynthesis in Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35955852","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31863983","id":"PMC_31863983","title":"Exposure of DBP in gestation induces inflammation of testicular Sertoli cells in progeny by activating NLRP3 inflammasomes.","date":"2019","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/31863983","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26586371","id":"PMC_26586371","title":"Plasticizer DBP Activates NLRP3 Inflammasome through the P2X7 Receptor in HepG2 and L02 Cells.","date":"2015","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/26586371","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31201960","id":"PMC_31201960","title":"Effects of bok choy on the dissipation of dibutyl phthalate (DBP) in mollisol and its possible mechanisms of biochemistry and microorganisms.","date":"2019","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/31201960","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25728413","id":"PMC_25728413","title":"Gestational and lactational exposition to Di-N-butyl-phthalate (DBP) increases inflammation and preneoplastic lesions in prostate of wistar rats after carcinogenic N-methyl-N-nitrosourea (MNU) plus testosterone protocol.","date":"2015","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25728413","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22019469","id":"PMC_22019469","title":"The teratogenicity and behavioral teratogenicity of di(2-ethylhexyl) phthalate (DEHP) and di-butyl phthalate (DBP) in a chick model.","date":"2011","source":"Neurotoxicology and teratology","url":"https://pubmed.ncbi.nlm.nih.gov/22019469","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33004990","id":"PMC_33004990","title":"Intrauterine exposure to low-dose DBP in the mice induces obesity in offspring via suppression of UCP1 mediated ER stress.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33004990","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34291709","id":"PMC_34291709","title":"DBP-GAPred: An intelligent method for prediction of DNA-binding proteins types by enhanced evolutionary profile features with ensemble learning.","date":"2021","source":"Journal of bioinformatics and computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/34291709","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35804233","id":"PMC_35804233","title":"Integrated toxicity assessment of DEHP and DBP toward aquatic ecosystem based on multiple trophic model assays.","date":"2022","source":"Environmental science and pollution research international","url":"https://pubmed.ncbi.nlm.nih.gov/35804233","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34280466","id":"PMC_34280466","title":"Environmentally relevant perinatal exposure to DBP disturbs testicular development and puberty onset in male mice.","date":"2021","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34280466","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27022680","id":"PMC_27022680","title":"PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter.","date":"2016","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27022680","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21458520","id":"PMC_21458520","title":"Circadian transcriptional factor DBP regulates expression of Kiss1 in the anteroventral periventricular nucleus.","date":"2011","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21458520","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14696974","id":"PMC_14696974","title":"The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone.","date":"2003","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/14696974","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35696964","id":"PMC_35696964","title":"Sporoderm-broken spores of Ganoderma lucidum alleviates liver injury induced by DBP and BaP co-exposure in rat.","date":"2022","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/35696964","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20563931","id":"PMC_20563931","title":"Functional and morphological reproductive aspects in male rats exposed to di-n-butyl phthalate (DBP) in utero and during lactation.","date":"2010","source":"Journal of toxicology and environmental health. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20563931","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30053495","id":"PMC_30053495","title":"Maternal exposure to di-n-butyl phthalate (DBP) promotes epithelial-mesenchymal transition via regulation of autophagy in uroepithelial cell.","date":"2018","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/30053495","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30525579","id":"PMC_30525579","title":"Differences in Root Physiological and Proteomic Responses to Dibutyl Phthalate Exposure between Low- and High-DBP-Accumulation Cultivars of Brassica parachinensis.","date":"2018","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30525579","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34088152","id":"PMC_34088152","title":"USP15 participates in DBP-induced testicular oxidative stress injury through regulating the Keap1/Nrf2 signaling pathway.","date":"2021","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/34088152","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3675739","id":"PMC_3675739","title":"Polymorphism of the vitamin D binding protein (DBP) among primates: an evolutionary analysis.","date":"1987","source":"American journal of physical anthropology","url":"https://pubmed.ncbi.nlm.nih.gov/3675739","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24504631","id":"PMC_24504631","title":"Co-metabolic biodegradation of DBP by Paenibacillus sp. S-3 and H-2.","date":"2014","source":"Current microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/24504631","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29683662","id":"PMC_29683662","title":"Global Picture of Protein Regulation in Response to Dibutyl Phthalate (DBP) Stress of Two Brassica parachinensis Cultivars Differing in DBP Accumulation.","date":"2018","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29683662","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32904102","id":"PMC_32904102","title":"Four patients with D-bifunctional protein (DBP) deficiency: Expanding the phenotypic spectrum of a highly variable disease.","date":"2020","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/32904102","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12462412","id":"PMC_12462412","title":"Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains.","date":"2002","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/12462412","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21657945","id":"PMC_21657945","title":"Differential expression of the Wnt/β-catenin pathway in the genital tubercle (GT) of fetal male rat following maternal exposure to di-n-butyl phthalate (DBP).","date":"2011","source":"Systems biology in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21657945","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15583024","id":"PMC_15583024","title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.","date":"2004","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15583024","citation_count":1274,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20541252","id":"PMC_20541252","title":"Common genetic determinants of vitamin D insufficiency: a genome-wide association study.","date":"2010","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20541252","citation_count":1249,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15951480","id":"PMC_15951480","title":"Vitamin D.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15951480","citation_count":1008,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20418485","id":"PMC_20418485","title":"Genome-wide association study of circulating vitamin D levels.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20418485","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21416506","id":"PMC_21416506","title":"Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21416506","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11717447","id":"PMC_11717447","title":"Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11717447","citation_count":238,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18593774","id":"PMC_18593774","title":"Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.","date":"2008","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18593774","citation_count":210,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19116321","id":"PMC_19116321","title":"Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women.","date":"2008","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/19116321","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20363324","id":"PMC_20363324","title":"A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations.","date":"2010","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20363324","citation_count":177,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2416779","id":"PMC_2416779","title":"Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family.","date":"1985","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2416779","citation_count":167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19302999","id":"PMC_19302999","title":"Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation.","date":"2009","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19302999","citation_count":158,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2415977","id":"PMC_2415977","title":"Human group-specific component (Gc) is a member of the albumin family.","date":"1985","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2415977","citation_count":154,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20733087","id":"PMC_20733087","title":"First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.","date":"2010","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/20733087","citation_count":133,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19255064","id":"PMC_19255064","title":"Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19255064","citation_count":132,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22916037","id":"PMC_22916037","title":"Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22916037","citation_count":132,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12048248","id":"PMC_12048248","title":"Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12048248","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20809279","id":"PMC_20809279","title":"Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20809279","citation_count":119,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1352271","id":"PMC_1352271","title":"Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1352271","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49735,"output_tokens":6184,"usd":0.120983},"stage2":{"model":"claude-opus-4-6","input_tokens":9861,"output_tokens":2842,"usd":0.180533},"total_usd":0.637534,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":63932,"output_tokens":6234,"usd":0.142653},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9612,"output_tokens":3234,"usd":0.193365}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"DBP (albumin D-site-binding protein) is a transcriptional activator that binds to the D site of the albumin promoter; it belongs to the bZIP family of transcription factors but lacks a classical leucine zipper. Tissue specificity is determined post-transcriptionally (protein present only in liver despite mRNA in most tissues), and expression is down-regulated during liver regeneration.\",\n      \"method\": \"cDNA cloning, protein expression analysis across tissues, liver regeneration model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original cloning paper with multiple experimental approaches; foundational study\",\n      \"pmids\": [\"2331750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"DBP protein accumulates in hepatocyte nuclei according to a strict circadian rhythm, peaking around 8 pm and undetectable in the morning; this oscillation is transcriptionally regulated and free-running, and correlates with increased albumin gene transcription in the evening.\",\n      \"method\": \"Nuclear protein extraction, immunoblotting, run-on transcription assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct biochemical demonstration of circadian nuclear accumulation and transcriptional correlation; foundational study replicated by multiple subsequent labs\",\n      \"pmids\": [\"2261643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"DBP activates the cholesterol 7-alpha hydroxylase (C7αH) promoter through a cognate DNA binding site centered around -225, and is a component of an evening-specific nuclear complex at this site; DBP circadian expression drives circadian transcription of C7αH in liver.\",\n      \"method\": \"Cotransfection assays, DNase I footprinting, nuclear extract binding assays, in vivo nuclear factor occupancy\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (footprinting, cotransfection, in vivo occupancy) in single study\",\n      \"pmids\": [\"8405996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"DBP and its chicken ortholog VBP (vitellogenin gene-binding protein) are related bZIP transcription factors that bind DNA as dimers and are stable dimers in solution; despite near-identical basic/hinge regions, they have distinct optimal DNA binding sites, defining a novel bZIP subfamily.\",\n      \"method\": \"cDNA library screening, sequence analysis, gel mobility shift assay, dimerization studies\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical characterization of dimerization and DNA binding specificity with multiple methods\",\n      \"pmids\": [\"1922023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"DBP directly activates the CYP2C6 (cytochrome P450) gene promoter through a binding site between -38 and -103 bp upstream of the transcription start site; DNase I footprinting identified the DBP footprint at -43 to -64 bp, and transactivation is liver-specific.\",\n      \"method\": \"Transient transfection, DNase I footprinting, gel mobility shift assay, Western immunoblot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro footprinting plus functional transfection plus direct protein binding validated by immunoblot\",\n      \"pmids\": [\"1588973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"DBP and LAP (C/EBP family) transactivate the alpha-2,6-sialyltransferase liver-restricted promoter through identified cis-elements; DBP binding site in this promoter was identified by footprinting.\",\n      \"method\": \"DNase I footprinting, 5' deletion analysis, site-directed mutagenesis, cotransfection with DBP expression vectors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — footprinting, mutagenesis, and functional transactivation assays combined\",\n      \"pmids\": [\"1737800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"DBP synergizes with C/EBP to transactivate the factor IX promoter; a Leyden mutation at position -5 in the factor IX gene disrupts protein binding, and post-pubertal induction of DBP compensates for this defect through a synergistic interaction between DBP and C/EBP.\",\n      \"method\": \"Transcription factor binding site mapping, cotransfection, electrophoretic mobility shift assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic epistasis via genetic mutation combined with binding and transactivation assays\",\n      \"pmids\": [\"8499951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"DBP mRNA oscillates strongly in the suprachiasmatic nucleus (SCN) with peak levels ~4 h earlier than in liver; DBP-null mice have shorter free-running circadian period and reduced locomotor activity, placing DBP in the circadian output pathway rather than the core oscillator.\",\n      \"method\": \"In situ hybridization, DBP knockout mouse phenotyping (locomotor activity, free-running period)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with defined behavioral phenotype, replicated in subsequent studies\",\n      \"pmids\": [\"9362490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DBP regulates circadian expression of Cyp2a4 (steroid 15α-hydroxylase) and Cyp2a5 (coumarin 7-hydroxylase) in mouse liver; in dbp-null mice the circadian amplitude of CYP2A4 and CYP2A5 mRNA and protein is significantly impaired; DBP binds to and footprints the Cyp2a4 and Cyp2a5 promoters.\",\n      \"method\": \"In vitro DNase I footprinting, cotransfection in HepG2 cells, dbp-null mouse genetic studies, mRNA/protein expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — footprinting plus cotransfection plus in vivo genetic validation with knockout mice\",\n      \"pmids\": [\"10490589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Circadian DBP transcription requires the bHLH-PAS protein CLOCK, which binds E-box motifs in the first and second introns of the Dbp gene; CLOCK regulates Dbp expression via the same E-box mechanism used for clock gene (mPeriod1) regulation.\",\n      \"method\": \"Genetic (CLOCK-mutant mice) and biochemical (E-box binding) experiments\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic and biochemical experiments combined, foundational mechanistic finding replicated by multiple labs\",\n      \"pmids\": [\"10733528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DBP directly binds to the mPer1 promoter and activates its transcription; CLOCK-BMAL1 and DBP cooperatively activate the mPer1 promoter; dbp transcription is activated by CLOCK-BMAL1 through E-boxes and inhibited by mPER and mCRY proteins.\",\n      \"method\": \"Promoter-reporter cotransfection assays, electrophoretic mobility shift assay (direct DBP binding to mPer1 promoter)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding demonstrated plus functional promoter assays\",\n      \"pmids\": [\"10848603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DBP-null mice show reduced amplitude of circadian modulation of sleep, reduced consolidation of sleep episodes, marked reduction in sleep-wake-dependent EEG delta power amplitude, increased hippocampal theta frequency, and absence of paradoxical sleep rebound after deprivation.\",\n      \"method\": \"EEG/EMG recording in dbp-/- vs dbp+/+ mice under light-dark and constant dark conditions, with sleep deprivation protocol\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with multiple defined physiological phenotypes\",\n      \"pmids\": [\"10632591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"AAV-mediated overexpression of DBP in rat hippocampus upregulates mRNAs for molecular clock components and the DBP target gene pyridoxal kinase; DBP overexpression inhibits spatial learning but not memory, enhances seizure susceptibility, and activates MAP kinase in dendritic regions of hippocampal neurons.\",\n      \"method\": \"Recombinant AAV gene expression, microarray, behavioral testing, immunohistochemistry for MAP kinase\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — viral overexpression with behavioral and signaling readouts in single study\",\n      \"pmids\": [\"16257226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Circadian DBP transcription is driven by rhythmic binding of BMAL1 and CLOCK to multiple E-box motifs in the Dbp gene (extra- and intragenic); active transcription correlates with H3K9 acetylation, H3K4 trimethylation and reduced histone density; repression correlates with H3K9 dimethylation, HP1α binding and increased histone density. Functional BMAL1-CLOCK binding sites are required for chromatin transitions.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), histone modification analysis, genetic (BMAL1 mutant) studies\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP with multiple histone marks plus genetic validation; highly cited foundational study\",\n      \"pmids\": [\"16474407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAR bZIP proteins DBP, TEF, and HLF collectively control circadian expression of many detoxification enzymes (cytochrome P450s, carboxylesterases) and the constitutive androstane receptor (CAR) in liver and kidney; triple knockout mice are hypersensitive to xenobiotics.\",\n      \"method\": \"PAR bZip triple knockout mice, liver/kidney transcriptome comparison, xenobiotic sensitivity assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic triple knockout with transcriptome and functional xenobiotic challenge\",\n      \"pmids\": [\"16814730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DBP/TEF/HLF triple knockout mice develop cardiac hypertrophy and left ventricular dysfunction with low blood pressure and abnormally low aldosterone levels, demonstrating a role for these PAR bZIP transcription factors in circadian regulation of cardiovascular function.\",\n      \"method\": \"PAR bZip triple knockout mouse cardiac phenotyping (echocardiography, blood pressure, aldosterone measurement)\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic model with multiple physiological readouts\",\n      \"pmids\": [\"20686175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cell-autonomous knockdown of DBP shortens the circadian period of Per1 and Per2 promoter-driven rhythms in Rat-1 fibroblasts, while overexpression lengthens it; E4BP4 (D-box negative regulator) has opposite effects, demonstrating that D-box regulators determine period length.\",\n      \"method\": \"siRNA knockdown and cDNA overexpression in Rat-1 fibroblasts with bioluminescent reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous loss-of-function and gain-of-function with quantitative reporter readout\",\n      \"pmids\": [\"21635892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DBP activates Kiss1 transcription in the anteroventral periventricular nucleus (AVPV) through D-box elements in the Kiss1 promoter; this activation synergizes with estrogen receptor alpha (ERα) and estrogen; some AVPV cells co-express DBP and ERα.\",\n      \"method\": \"Promoter-reporter cotransfection, immunohistochemistry (co-localization of DBP and ERα), qPCR of DBP mRNA rhythm\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional promoter assay plus histological co-localization in single study\",\n      \"pmids\": [\"21458520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BMAL1 binding to Dbp chromatin is highly circadian and strictly CLOCK-dependent; BMAL1-CLOCK associations with Dbp are extremely unstable and show stochastic, proteasome-dependent fluctuations. Proteasome inhibition prolongs BMAL1-CLOCK residence time but immediately attenuates Dbp transcription by decreasing frequency and size of transcriptional bursts — BMAL1-CLOCK act as 'Kamikaze activators' at the Dbp locus.\",\n      \"method\": \"Live-cell time-lapse microscopy of fluorescent BMAL1 at tandem Dbp repeat arrays, proteasome inhibition, single-copy Dbp-luciferase reporter, FRAP-like analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — real-time live imaging plus functional reporter assays plus pharmacological perturbation; multiple orthogonal methods\",\n      \"pmids\": [\"22981862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PI3K signaling modulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter; pharmacological inhibition or shRNA knockdown of PI3K blocks serum shock-induced Dbp mRNA upregulation, reduces Dbp promoter activity, decreases BMAL1/CLOCK recruitment to the E-box, and blocks BMAL1-CLOCK heterodimerization.\",\n      \"method\": \"shRNA knockdown, pharmacological PI3K inhibition, promoter-reporter assay, ChIP\",\n      \"journal\": \"Bioscience, biotechnology, and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods in single study but single lab\",\n      \"pmids\": [\"27022680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DEC2 (but not DEC1) suppresses DBP-driven transcription of cholesterol 7α-hydroxylase (CYP7A), CYP8B, and CYP51 by binding to E-box elements (CACATG at -219/-214 of CYP7A), acting as a direct output mediator opposing DBP in circadian regulation of hepatic P450s.\",\n      \"method\": \"Transfection assays, electrophoretic mobility shift assay (DEC2 binding to E-box)\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding demonstrated plus functional assay; single study\",\n      \"pmids\": [\"15066123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human DBP gene maps to chromosome 19q13; human DBP is a PAR bZIP transcription factor with highly conserved coding sequences (including PAR region and bZIP domain) relative to rat DBP; conserved exon-intron boundaries of the bZIP domain suggest derivation from a common ancestral gene with TEF.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH), somatic cell hybrid mapping, cDNA cloning, sequence analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping and structural characterization\",\n      \"pmids\": [\"7835883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DBP is converted to DBP-maf (macrophage activating factor) by post-translational selective deglycosylation of galactose and sialic acid from its third domain; baculovirus-expressed (glycosylated) recombinant DBP-maf activates osteoclasts in a dose-dependent manner, but E. coli-expressed (non-glycosylated) recombinant DBP shows no osteoclast-activating activity; vitamin D binding site occupancy does not influence this activity.\",\n      \"method\": \"In vitro osteoclast pit formation assay, baculovirus vs E. coli expression systems, native and recombinant protein comparison\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional in vitro assay with glycosylation-dependent mechanistic dissection using multiple protein forms\",\n      \"pmids\": [\"11255236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DBP-maf inhibits endothelial cell proliferation, is antiangiogenic in CAM assay, and inhibits tumor growth in vivo; treated tumors show higher macrophage infiltration, reduced microvessel density, and increased apoptosis.\",\n      \"method\": \"In vitro endothelial proliferation assay, chorioallantoic membrane assay, mouse tumor xenograft model, histology\",\n      \"journal\": \"Neoplasia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo functional assays in single study\",\n      \"pmids\": [\"12659668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DBP-maf inhibits angiogenesis by blocking VEGF-induced endothelial cell proliferation (S- and G0/G1-phase arrest), migration, and tube formation; mechanistically, DBP-maf decreases VEGF-mediated phosphorylation of VEGFR-2 and ERK1/2 but does not affect Akt activation.\",\n      \"method\": \"Endothelial cell proliferation/migration/tube formation assays, rat aortic ring assay, Western blot for VEGFR-2 and ERK1/2 phosphorylation\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays plus signaling mechanism in single study\",\n      \"pmids\": [\"16400520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Human and bovine vitamin D-binding protein (DBP) binds fatty acids (primarily oleic and palmitic acids, monounsaturated and saturated) with molar ratios of ~0.4-1.3 fatty acid per protein molecule.\",\n      \"method\": \"Sequential protein purification (Cibacron Blue-Sepharose, gel filtration, DEAE, immunoadsorption), fatty acid analysis\",\n      \"journal\": \"Biochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical characterization of native protein-ligand interaction\",\n      \"pmids\": [\"2673244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HSD17B4/DBP (D-bifunctional protein) is a multifunctional peroxisomal enzyme; compound heterozygous mutations in HSD17B4 (p.Y217C destabilizing the dehydrogenase domain; p.Y568X causing low transcript) cause Perrault syndrome, showing that reduced DBP enzymatic activity leads to ovarian dysgenesis, sensorineural deafness, and ataxia — an attenuated form of classical DBP deficiency.\",\n      \"method\": \"Whole-exome sequencing, structural analysis of dehydrogenase domain mutation, transcript level analysis, protein expression assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — structural prediction validated with expression data plus clinical genetics; establishes enzymatic domain requirement\",\n      \"pmids\": [\"20673864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DBP-maf and a synthetic 14-amino-acid peptide corresponding to the glycosylation site in the third domain of DBP increase bone density in neonatal and adult rats; local injection of the peptide induces osteoinduction in bone marrow, demonstrating anabolic activity distinct from osteoclast activation.\",\n      \"method\": \"In vivo injection in rats, pQCT bone densitometry, histology and radiography\",\n      \"journal\": \"Critical reviews in eukaryotic gene expression\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional assay with defined peptide domain; single study\",\n      \"pmids\": [\"14696974\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DBP (albumin D-site-binding protein) is a PAR-domain bZIP transcription factor expressed in a CLOCK/BMAL1-driven circadian manner via E-box elements in its introns; it acts as an output regulator of the circadian clock by directly binding D-box elements to drive rhythmic transcription of target genes including cholesterol 7α-hydroxylase (CYP7A), cytochrome P450s (CYP2A4, CYP2A5, CYP2C6), and mPer1 (cooperatively with CLOCK-BMAL1), with BMAL1-CLOCK binding at the Dbp locus being proteasome-dependent and transient ('Kamikaze' activation); DBP-null mice have shorter circadian period, reduced locomotor activity, and disrupted sleep consolidation, and PAR bZIP triple knockout mice show impaired xenobiotic detoxification and cardiovascular dysfunction; additionally, a separate protein sharing the DBP acronym is vitamin D-binding protein (GC-globulin), a serum protein that transports vitamin D metabolites and, upon selective deglycosylation, generates DBP-maf, which activates osteoclasts in a glycosylation-dependent manner and inhibits angiogenesis by blocking VEGFR-2/ERK1/2 signaling.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\nThe target gene DBP here is the **PAR-domain bZIP transcription factor DBP** (albumin D-site binding protein, gene symbol DBP, also known as D-box binding PAR bZIP transcription factor). This is a circadian transcription factor expressed in liver and other tissues.\n\nHowever, the corpus also contains papers about:\n- **Vitamin D binding protein (DBP/GC gene)** — a different protein (EXCLUDE: alias collision)\n- **Dibutyl phthalate (DBP)** — a chemical plasticizer (EXCLUDE: not a gene)\n- **Plasmodium vivax Duffy Binding Protein (DBP)** — parasite protein (EXCLUDE: symbol collision, non-orthologous)\n- **D-bifunctional protein (DBP/HSD17B4)** — peroxisomal enzyme (EXCLUDE: different gene)\n- **DEAD-box protein DBP-RB** — different gene (EXCLUDE)\n- **DNA-binding proteins (DBPs)** — computational category (EXCLUDE)\n\n**KEEP papers** (about the PAR bZIP transcription factor DBP):\n- PMID:16474407, 16814730, 2331750, 10733528, 8405996, 9362490, 10848603, 10490589, 10632591, 1922023, 1737800, 8499951, 7835883, 1588973, 15066123, 21635892, 20686175, 16257226, 21458520, 27022680\n\n**EXCLUDE** (vitamin D binding protein, dibutyl phthalate chemical, P. vivax DBP, HSD17B4, etc.): all remaining papers.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"DBP was cloned as a transcriptional activator binding the D site of the albumin promoter; it belongs to the bZIP family (related to Fos, Jun, CREB, C/EBP) but lacks a canonical leucine zipper. DBP protein accumulates only in liver despite mRNA being present in most tissues, establishing that tissue specificity is determined post-transcriptionally. DBP expression is rapidly down-regulated during chemically induced liver regeneration, suggesting a role in hepatocyte proliferation control.\",\n      \"method\": \"cDNA cloning, Northern and Western blot across multiple rat tissues, liver regeneration model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original cloning paper with multiple orthogonal methods, foundational study\",\n      \"pmids\": [\"2331750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"DBP protein accumulates in rat hepatocyte nuclei according to a strict circadian rhythm, reaching maximum around 8 p.m. and falling below detection during morning hours. The oscillation is free-running (circadian, not simply diurnal), is regulated at the transcriptional level, and may be under negative control of glucocorticoid hormones. The albumin gene, a putative DBP target, is transcribed more efficiently in the evening than in the morning, consistent with DBP driving rhythmic albumin transcription.\",\n      \"method\": \"Western blot of nuclear extracts across time-points, nuclear run-on transcription assay, glucocorticoid treatment experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct biochemical measurement of protein oscillation with functional transcriptional readout, foundational paper\",\n      \"pmids\": [\"2261643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Chicken VBP (vitellogenin gene-binding protein) is the avian ortholog of rat DBP; both are bZIP proteins that dimerize and bind DNA as dimers. Despite only three amino acid differences in their basic/hinge regions, DBP's albumin D-site is a poor binding site for VBP, indicating distinct optimal DNA-binding sites. Their leucine zippers are functionally compatible (forming heterodimers) but define a novel bZIP subfamily.\",\n      \"method\": \"cDNA expression library screening, DNA-binding assays, dimerization studies, sequence comparison\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and dimerization assays; single lab\",\n      \"pmids\": [\"1922023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"DBP directly binds to and transactivates the CYP2C6 promoter in hepatoma cells through a sequence between -38 and -103 bp upstream of the transcription start site. DNase I footprinting with partially purified DBP confirmed a specific footprint at -43 to -64 bp. Gel-shift/Western immunoblot showed DBP binding is age-dependent, appearing only after 3 weeks of age in rats and reaching maximum by 7 weeks, paralleling the postnatal rise in CYP2C6 expression.\",\n      \"method\": \"Transient transfection in HepG2 cells, DNase I footprinting, gel mobility shift assay, Western immunoblot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical methods (footprinting, EMSA, transfection) in single study\",\n      \"pmids\": [\"1588973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"DBP, along with HNF-1α and LAP/C/EBP, regulates the liver-restricted promoter of the alpha-2,6-sialyltransferase gene. Footprinting and deletion analysis identified a consensus DBP/LAP binding cis-element essential for liver-specific expression; expression vectors encoding DBP trans-activated the sialyltransferase promoter in cotransfection assays, demonstrating that tissue-specific glycosylation can be regulated transcriptionally by the same liver-enriched factors controlling other liver-specific genes.\",\n      \"method\": \"DNase I footprinting, 5' deletion analysis, site-directed mutagenesis, cotransfection assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple methods; single lab\",\n      \"pmids\": [\"1737800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"DBP directly activates the cholesterol 7α-hydroxylase (C7αH) gene promoter through a cognate DNA site at approximately -225 bp, as shown by cotransfection assays. In nuclear extracts prepared by a novel method recovering near-quantitative DBP, the predominant binding activity at this promoter site in the evening (when DBP is high) was shown to contain DBP by supershift, providing direct evidence that DBP drives the circadian expression of C7αH, the rate-limiting enzyme in bile acid synthesis.\",\n      \"method\": \"Cotransfection assays, novel nuclear extract preparation, DNase I footprinting, gel shift/supershift assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods with direct in vivo occupancy evidence, replicated by genetic studies\",\n      \"pmids\": [\"8405996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"DBP synergizes with C/EBP to compensate for the haemophilia B Leyden factor IX -5 mutation. The -5 nucleotide substitution disrupts binding of proteins to one of three newly identified transcription factor binding sites in the factor IX promoter. Post-pubertal induction of DBP (which is induced at puberty) allows DBP and C/EBP to synergistically restore transcriptional activity of the mutant -5 promoter, explaining the clinical recovery seen after puberty in Leyden patients.\",\n      \"method\": \"Transcription factor binding site characterization, gel-shift assays, cotransfection/transactivation assays\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical and functional evidence; single lab with clear mechanistic model\",\n      \"pmids\": [\"8499951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Human DBP gene was cloned and chromosomally localized to 19q13; human TEF to 22q13. The coding sequences, particularly the bZIP domain and PAR region, are highly conserved between human and rat DBP. Conservation of exon-intron boundaries around the bZIP-encoding exon suggests derivation from a common ancestral gene shared with TEF and HLF. DBP mRNA was detected in all tissues examined (brain, lung, liver, spleen, kidney), consistent with broad but rhythmically controlled expression.\",\n      \"method\": \"cDNA cloning, FISH chromosomal mapping, somatic cell hybrid analysis, Northern blot\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cloning and chromosomal mapping; single lab\",\n      \"pmids\": [\"7835883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"DBP mRNA oscillates strongly in the suprachiasmatic nucleus (SCN) of the hypothalamus, with peak levels ~4 hours earlier than in liver, indicating tissue-specific control of circadian DBP expression. Dbp-null mice display reduced locomotor activity and a shorter free-running circadian period, establishing DBP as a modulator of circadian behavioral outputs. Since DBP-/- mice remain rhythmic and DBP is not required for circadian expression of its own gene, DBP functions in the circadian output pathway rather than as a core clock component.\",\n      \"method\": \"In situ hybridization in SCN, generation and analysis of Dbp-null mice (locomotor activity, free-running period)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined behavioral phenotype, replicated subsequently\",\n      \"pmids\": [\"9362490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DBP drives circadian expression of the Cyp2a4 (steroid 15α-hydroxylase) and Cyp2a5 (coumarin 7-hydroxylase) genes in mouse liver. In vitro DNase I footprinting on Cyp2a4 and Cyp2a5 promoters and cotransfection in HepG2 cells confirmed DBP can activate these promoters. Genetic validation using Dbp-null mice showed significantly impaired circadian amplitude of CYP2A4 and CYP2A5 mRNA and protein, establishing DBP as a major factor controlling their rhythmic hepatic expression.\",\n      \"method\": \"DNase I footprinting, cotransfection assays, Dbp-null mouse experiments (mRNA and protein quantification)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical and genetic evidence combined, multiple methods\",\n      \"pmids\": [\"10490589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DBP activates the mPer1 promoter by directly binding to it, and this activation is cooperative with CLOCK-BMAL1. Dbp transcription is itself activated by CLOCK-BMAL1 through E-boxes and repressed by mPER and mCRY proteins, placing DBP within the core circadian feedback loop as both a target and an amplifier of CLOCK-BMAL1 activity acting on Per1.\",\n      \"method\": \"Reporter gene assays (cotransfection), direct promoter binding assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding and functional reporter assays; single lab\",\n      \"pmids\": [\"10848603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Loss of DBP (Dbp-/- mice) reduces the amplitude of circadian modulation of sleep time and sleep episode consolidation under both light-dark and constant-dark conditions without affecting total sleep duration. DBP deficiency also reduces amplitude of sleep-wake-dependent changes in slow-wave sleep delta power, increases hippocampal theta peak frequency, and abolishes the paradoxical sleep rebound after sleep deprivation, establishing DBP as a transcriptional regulator of both circadian and homeostatic aspects of sleep.\",\n      \"method\": \"EEG/EMG recordings in Dbp-/- mice, sleep deprivation experiments, quantitative EEG analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with specific quantitative phenotypic readouts across multiple sleep parameters\",\n      \"pmids\": [\"10632591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CLOCK is required for circadian Dbp transcription. Genetic experiments with Clock-mutant mice and biochemical studies demonstrated that CLOCK binds to E-box motifs within putative enhancer regions in the first and second introns of the Dbp gene to drive its rhythmic expression. The same E-box mechanism that controls core clock gene mPeriod1 expression also directly controls the rhythmic transcription of the clock output regulator Dbp.\",\n      \"method\": \"Analysis of Clock-mutant mice (Dbp mRNA levels), electrophoretic mobility shift assays, reporter gene assays with E-box mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic and biochemical evidence combined, replicated by later chromatin studies\",\n      \"pmids\": [\"10733528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DEC2 (but not DEC1) suppresses DBP-mediated transcriptional activation of the cholesterol 7α-hydroxylase (CYP7A) gene by binding to an E-box (CACATG) at -219/-214 of CYP7A, overwhelming DBP's potent enhancement. This establishes a mechanistic antagonism where the clock-controlled repressor DEC2 opposes the clock-controlled activator DBP to regulate rhythmic cytochrome P450 expression in the liver.\",\n      \"method\": \"Transfection reporter assays, electrophoretic mobility shift assays (EMSA)\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct EMSA and functional reporter assays defining antagonism; single lab\",\n      \"pmids\": [\"15066123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hippocampal over-expression of DBP (via rAAV) in adult rats upregulates molecular clock constituents and the DBP target gene pyridoxal kinase. DBP over-expression inhibits spatial learning (but not memory), enhances susceptibility to kainate-induced seizures, and activates MAP kinase in dendritic regions of hippocampal neurons in vivo, establishing DBP as a transcriptional link between GLP-1R activation and hippocampal neuroplasticity.\",\n      \"method\": \"rAAV-mediated gene delivery, microarray analysis, behavioral testing (water maze), kainate seizure model, in vivo MAP kinase immunostaining\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function with defined behavioral and molecular phenotypes; single lab\",\n      \"pmids\": [\"16257226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Circadian Dbp transcription is driven by rhythmic binding of BMAL1 and CLOCK to multiple extra- and intragenic E-box motifs. This binding is accompanied by marked daily chromatin transitions: the transcriptionally active phase shows acetylation of H3K9, trimethylation of H3K4, and reduced histone density, while the repressive phase shows dimethylation of H3K9, binding of heterochromatin protein 1α (HP1α), and increased histone density. The rhythmic conversion between permissive chromatin and facultative heterochromatin requires functional BMAL1-CLOCK binding sites.\",\n      \"method\": \"ChIP assays (BMAL1, CLOCK, histone modifications, HP1α) across circadian time-points, E-box mutant analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — comprehensive ChIP-based chromatin analysis across multiple marks, strong mechanistic detail, highly cited\",\n      \"pmids\": [\"16474407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAR bZIP proteins DBP, TEF, and HLF control expression of many enzymes involved in xenobiotic detoxification and drug metabolism in liver and kidney, including cytochrome P450 enzymes, carboxylesterases, and constitutive androstane receptor (CAR). Triple knockout mice (Dbp/Tef/Hlf -/-) are hypersensitive to xenobiotic compounds, and the deficiency in detoxification contributes to their early aging and premature death phenotype.\",\n      \"method\": \"Triple knockout mouse generation and analysis, liver/kidney transcriptome comparison, xenobiotic challenge experiments\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with transcriptome and physiological phenotype, multiple orthogonal approaches\",\n      \"pmids\": [\"16814730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Triple PAR bZIP knockout mice (Dbp/Tef/Hlf -/-) develop cardiac hypertrophy and left ventricular dysfunction associated with low blood pressure and abnormally low aldosterone levels, demonstrating that PAR bZIP transcription factors (including DBP) are required for normal circadian regulation of cardiovascular function.\",\n      \"method\": \"Echocardiography, blood pressure measurement, aldosterone assays in triple PAR bZIP knockout mice\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined cardiovascular phenotypes; attribution shared among three PAR bZIPs\",\n      \"pmids\": [\"20686175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cell-autonomous siRNA knockdown of DBP in Rat-1 fibroblasts produces a short-period circadian phenotype, while DBP overexpression produces a long-period rhythm in Per1 and Per2 promoter-driven bioluminescence reporters. Conversely, knockdown/overexpression of E4BP4 (the D-box repressor) has the opposite effect. This establishes that DBP (D-box activator) and E4BP4 (D-box repressor) are critical cell-autonomous determinants of circadian period length.\",\n      \"method\": \"siRNA knockdown, cDNA overexpression, bioluminescent circadian reporter assays in Rat-1 fibroblasts\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous genetic perturbation with quantitative circadian readout; single lab\",\n      \"pmids\": [\"21635892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DBP binds to a D-box element in the Kiss1 promoter in the anteroventral periventricular nucleus (AVPV) and triggers Kiss1 transcription; this effect is synergistic with estrogen receptor α (ERα) and estrogen. Dbp mRNA accumulates with a robust diurnal rhythm in the AVPV specifically on proestrus (but not diestrus), and some AVPV cells co-express DBP and ERα. This establishes DBP as a circadian transcriptional regulator linking the clock to the GnRH/LH surge through Kiss1.\",\n      \"method\": \"Reporter gene/cotransfection assays with D-box mutations, in situ hybridization, immunohistochemistry of AVPV\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding assay combined with anatomical co-expression data; single lab\",\n      \"pmids\": [\"21458520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BMAL1-CLOCK associations with Dbp chromatin are extremely unstable, showing stochastic, proteasome-dependent fluctuations monitored in real time by fluorescent BMAL1 at tandem Dbp repeat arrays. Proteasome inhibition prolongs BMAL1-CLOCK residence time but immediately attenuates Dbp transcription by decreasing both the frequency and size of transcriptional bursts. This reveals that BMAL1 and CLOCK act as 'Kamikaze activators' that must be rapidly degraded after binding to sustain transcriptional cycling.\",\n      \"method\": \"Live-cell fluorescence time-lapse microscopy of BMAL1-GFP at Dbp locus arrays, proteasome inhibition, single-copy Dbp-luciferase reporter analysis of transcriptional bursting\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution-level live imaging with pharmacological perturbation and single-gene reporter, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"22981862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PI3K signaling is required for BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter. Pharmacological inhibition or shRNA knockdown of PI3K blocked serum-shock-induced upregulation of Dbp mRNA and reduced Dbp promoter activity. PI3K inhibition decreased recruitment of BMAL1/CLOCK to the E-box in the Dbp promoter and blocked BMAL1-CLOCK heterodimerization, establishing PI3K as an upstream modulator of the circadian transcriptional complex at Dbp.\",\n      \"method\": \"Pharmacological PI3K inhibition, shRNA knockdown, RT-PCR, luciferase reporter assays, ChIP assay (BMAL1 at E-box), co-immunoprecipitation of BMAL1-CLOCK\",\n      \"journal\": \"Bioscience, biotechnology, and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (ChIP, co-IP, reporter, KD) in single study; single lab\",\n      \"pmids\": [\"27022680\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DBP is a PAR-domain bZIP transcription factor that accumulates in a strict circadian rhythm (driven by CLOCK-BMAL1 binding to intronic E-boxes with accompanying chromatin transitions from permissive to facultative heterochromatin) and functions as a clock output regulator by directly binding D-box elements to activate target genes involved in cholesterol/bile acid metabolism (CYP7A1), drug detoxification (CYP2A4, CYP2A5, CYP2C6, xenobiotic enzymes), and neuroendocrine control (Kiss1, mPer1); loss of DBP shortens circadian period, reduces locomotor activity amplitude, disrupts sleep consolidation and EEG rhythms, and—together with the other PAR bZIP factors TEF and HLF—causes hypersensitivity to xenobiotics and cardiovascular dysfunction, while BMAL1-CLOCK drive Dbp transcription through a 'Kamikaze activator' mechanism requiring rapid proteasomal degradation of the transcriptional complex to sustain transcriptional bursting.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DBP (albumin D-site-binding protein) is a PAR-domain bZIP transcription factor that functions as a major circadian clock output regulator, translating core clock signals into rhythmic gene expression in liver, brain, and other tissues. Its own transcription is driven by CLOCK/BMAL1 binding to E-box elements within its introns, with chromatin remodeling involving cyclic H3K9 acetylation and H3K4 trimethylation, and transient, proteasome-dependent 'Kamikaze' activator dynamics at the locus [PMID:16474407, PMID:22981862]. DBP binds D-box cis-elements to activate circadian transcription of targets including cholesterol 7α-hydroxylase (CYP7A), cytochrome P450s (CYP2A4/5, CYP2C6), mPer1 (cooperatively with CLOCK-BMAL1), and Kiss1, and together with the related PAR bZIP factors TEF and HLF it controls xenobiotic detoxification pathways and cardiovascular homeostasis [PMID:8405996, PMID:10490589, PMID:10848603, PMID:16814730, PMID:20686175]. DBP-null mice display shortened circadian period, reduced locomotor activity, disrupted sleep consolidation, and impaired EEG delta power modulation, establishing DBP as a determinant of circadian period length and sleep architecture [PMID:9362490, PMID:10632591, PMID:21635892].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Identifying DBP as a novel bZIP transcription factor with liver-enriched nuclear accumulation and strict circadian oscillation established that a transcription factor could serve as a time-of-day signal in gene regulation.\",\n      \"evidence\": \"cDNA cloning, tissue protein surveys, nuclear immunoblotting, and run-on transcription assays in rat liver\",\n      \"pmids\": [\"2331750\", \"2261643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism driving post-transcriptional tissue restriction unknown\", \"Upstream regulator of circadian DBP transcription not identified\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstrating that DBP forms stable dimers and belongs to a distinct bZIP subfamily (with VBP/TEF) defined the structural basis for its DNA-binding specificity at D-box elements.\",\n      \"evidence\": \"Gel shift and dimerization assays comparing DBP and chicken VBP binding-site preferences\",\n      \"pmids\": [\"1922023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of DBP-DNA complex not determined\", \"Heterodimerization partners within the PAR bZIP family not systematically tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Showing that DBP directly activates the cholesterol 7α-hydroxylase and CYP2C6 promoters via cognate D-box sites established DBP as a transcriptional driver of hepatic metabolic gene rhythms.\",\n      \"evidence\": \"DNase I footprinting, cotransfection, and in vivo nuclear occupancy assays on CYP7A and CYP2C6 promoters\",\n      \"pmids\": [\"8405996\", \"1588973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DBP is sufficient vs. necessary for circadian P450 expression not resolved\", \"In vivo ChIP confirmation at these loci not yet performed\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Discovery that DBP synergizes with C/EBP to activate factor IX transcription, and that a Leyden mutation disrupts this synergy, linked DBP to haemophilia B Leyden pathophysiology and demonstrated combinatorial transcription factor logic.\",\n      \"evidence\": \"Cotransfection, EMSA, and mutation analysis of factor IX promoter\",\n      \"pmids\": [\"8499951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct in vivo role of DBP at factor IX locus not confirmed in knockout mice\", \"Whether pubertal DBP induction rescues factor IX levels in patients not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Generating DBP-null mice revealed a shortened circadian free-running period and reduced locomotor activity, positioning DBP as a circadian output regulator that modulates period length rather than an essential core oscillator component.\",\n      \"evidence\": \"DBP knockout mice with locomotor activity recording under constant darkness\",\n      \"pmids\": [\"9362490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets mediating the period phenotype not identified\", \"Redundancy with TEF and HLF not dissected\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that CYP2A4/5 circadian amplitude collapses in dbp-null mice confirmed that DBP is necessary, not merely correlated, for rhythmic P450 expression in vivo.\",\n      \"evidence\": \"DNase I footprinting on Cyp2a4/5 promoters plus mRNA/protein analysis in dbp−/− mice\",\n      \"pmids\": [\"10490589\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of TEF/HLF to residual rhythmicity not assessed\", \"Whether DBP directly drives CYP protein stability changes unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that CLOCK binds E-box motifs in Dbp introns and that DBP cooperatively activates the mPer1 promoter with CLOCK-BMAL1 defined a feedforward circuit connecting the core clock to D-box-dependent output.\",\n      \"evidence\": \"CLOCK-mutant mice, E-box binding assays, promoter-reporter cotransfection for mPer1\",\n      \"pmids\": [\"10733528\", \"10848603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of DBP vs. CLOCK-BMAL1 to mPer1 amplitude not resolved\", \"Whether feedforward loop is essential for period determination unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"DBP-null mice showed disrupted sleep consolidation, reduced EEG delta power modulation, and absent paradoxical sleep rebound, establishing DBP as a molecular link between the circadian clock and sleep homeostasis.\",\n      \"evidence\": \"EEG/EMG recording in dbp−/− mice under LD and DD conditions with sleep deprivation\",\n      \"pmids\": [\"10632591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating sleep phenotype not identified\", \"Cell-type-specific DBP function in sleep circuits not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genome-wide chromatin profiling at the Dbp locus revealed that BMAL1-CLOCK binding drives rhythmic histone acetylation/methylation transitions, establishing the epigenetic mechanism underlying circadian Dbp transcription.\",\n      \"evidence\": \"ChIP for BMAL1, CLOCK, H3K9ac, H3K4me3, H3K9me2, HP1α at Dbp; BMAL1 mutant validation\",\n      \"pmids\": [\"16474407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of histone modifying enzymes recruited to Dbp not determined\", \"Whether chromatin cycle is cause or consequence of transcriptional bursting unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"PAR bZIP triple knockout (DBP/TEF/HLF) mice revealed that these factors collectively control xenobiotic detoxification enzyme expression and sensitivity, demonstrating functional redundancy and a critical role in drug metabolism.\",\n      \"evidence\": \"Triple knockout mice with liver/kidney transcriptomics and xenobiotic challenge\",\n      \"pmids\": [\"16814730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of each PAR bZIP to specific target genes not fully resolved\", \"Whether detoxification phenotype is circadian-phase-dependent not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"PAR bZIP triple knockout mice develop cardiac hypertrophy with low aldosterone, extending the physiological scope of DBP/TEF/HLF from metabolism to cardiovascular homeostasis.\",\n      \"evidence\": \"Echocardiography, blood pressure, and aldosterone measurements in triple knockout mice\",\n      \"pmids\": [\"20686175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DBP target genes in cardiomyocytes or adrenal cortex not identified\", \"Single DBP knockout cardiac phenotype not reported\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Live-cell imaging revealed that BMAL1-CLOCK binding at Dbp is transient and proteasome-dependent, with inhibition of the proteasome paradoxically attenuating transcription — establishing a 'Kamikaze activator' model where rapid turnover drives transcriptional bursting.\",\n      \"evidence\": \"Fluorescent BMAL1 imaging at tandem Dbp arrays, proteasome inhibition, single-copy luciferase reporter\",\n      \"pmids\": [\"22981862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which ubiquitin ligase targets BMAL1 at Dbp not identified\", \"Whether Kamikaze mechanism applies to other CLOCK-BMAL1 targets unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the direct transcriptional targets of DBP that mediate its sleep and circadian-period phenotypes, the cell-type-specific functions of DBP in the SCN and other brain regions, and the structural basis for DBP-DNA recognition at D-box elements.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of DBP or DBP-DNA complex\", \"Cell-type-specific conditional knockouts not reported\", \"Direct targets underlying sleep phenotype not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3, 4, 8, 10]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 4, 5, 6, 8, 10, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009909396\", \"supporting_discovery_ids\": [1, 7, 9, 10, 11, 13, 16, 18]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 4, 5, 6, 8, 10, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CLOCK\",\n      \"BMAL1\",\n      \"CEBP\",\n      \"TEF\",\n      \"HLF\",\n      \"ESR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"DBP is a PAR-domain basic leucine zipper (bZIP) transcription factor that functions as a principal circadian clock output regulator, linking the core CLOCK–BMAL1 oscillator to rhythmic gene expression in liver, brain, and neuroendocrine tissues. CLOCK–BMAL1 drives Dbp transcription through intronic and extragenic E-box elements accompanied by circadian chromatin remodeling between permissive (H3K9ac, H3K4me3) and facultative heterochromatin (H3K9me2, HP1α) states, with sustained transcriptional bursting dependent on rapid proteasomal turnover of the BMAL1–CLOCK complex [PMID:16474407, PMID:22981862]. DBP protein accumulates with a high-amplitude circadian rhythm and directly activates D-box-containing promoters of genes governing cholesterol/bile acid metabolism (CYP7A1), xenobiotic detoxification (CYP2A4/5, CYP2C6, CAR), the core clock (mPer1), and reproductive neuroendocrine signaling (Kiss1), functioning redundantly with the PAR bZIP factors TEF and HLF [PMID:8405996, PMID:10490589, PMID:16814730, PMID:21458520]. Dbp-null mice exhibit a shortened free-running circadian period, reduced locomotor activity amplitude, disrupted sleep consolidation, and impaired EEG slow-wave and theta rhythms, while compound loss of all three PAR bZIPs causes xenobiotic hypersensitivity, premature aging, and cardiovascular dysfunction [PMID:9362490, PMID:10632591, PMID:16814730, PMID:20686175].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Identification of DBP as a liver-enriched bZIP transcription factor with strict circadian protein accumulation established the first known mammalian transcriptional activator whose abundance oscillates with a free-running circadian rhythm.\",\n      \"evidence\": \"cDNA cloning from rat liver, Western blots across tissues and circadian time-points, nuclear run-on transcription assays\",\n      \"pmids\": [\"2331750\", \"2261643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism driving circadian mRNA/protein oscillation unknown\",\n        \"In vivo target genes beyond albumin not identified\",\n        \"Post-transcriptional mechanism restricting protein to liver not defined\"\n      ]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Demonstration that DBP directly binds and transactivates hepatic cytochrome P450 (CYP2C6) and sialyltransferase promoters extended DBP's role from albumin regulation to liver-specific drug metabolism and glycosylation programs.\",\n      \"evidence\": \"DNase I footprinting, EMSA, cotransfection reporter assays in HepG2 cells\",\n      \"pmids\": [\"1588973\", \"1737800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No loss-of-function evidence yet linking DBP to CYP2C6 expression in vivo\",\n        \"Relative contributions of DBP versus other liver-enriched factors (C/EBP, HNF) not delineated\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of DBP as a direct activator of cholesterol 7α-hydroxylase (CYP7A1) connected the circadian DBP oscillation to a rate-limiting metabolic step—bile acid synthesis—providing the first functional link between circadian clock output and intermediary metabolism.\",\n      \"evidence\": \"Cotransfection assays, supershift of evening nuclear extracts confirming DBP occupancy at CYP7A1 promoter\",\n      \"pmids\": [\"8405996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No genetic validation in Dbp-null animals for CYP7A1 regulation\",\n        \"Contribution of other D-box activators (TEF, HLF) not assessed\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Evidence that DBP synergizes with C/EBP to restore factor IX transcription from the Leyden -5 mutant promoter after puberty explained the clinical recovery in haemophilia B Leyden by invoking pubertal DBP induction.\",\n      \"evidence\": \"Gel-shift assays and cotransfection transactivation assays with mutant factor IX promoter\",\n      \"pmids\": [\"8499951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of pubertal DBP induction not defined\",\n        \"In vivo confirmation in patient-derived cells lacking\",\n        \"Relative importance of DBP versus androgen-responsive factors not resolved\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Generation of Dbp-null mice established that DBP is dispensable for core clock function but required for normal circadian period length and locomotor activity amplitude, positioning DBP as a clock output regulator rather than a core oscillator component.\",\n      \"evidence\": \"Dbp-knockout mice, locomotor activity recording under constant darkness, in situ hybridization in SCN\",\n      \"pmids\": [\"9362490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular targets responsible for shortened period not identified\",\n        \"Redundancy with TEF/HLF not tested genetically\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Phenotyping of Dbp-null mice for sleep architecture revealed that DBP regulates circadian modulation of sleep consolidation, EEG delta power, theta frequency, and paradoxical sleep rebound, establishing DBP as a transcriptional link between the clock and sleep homeostasis.\",\n      \"evidence\": \"EEG/EMG recordings in Dbp−/− mice under LD and DD, sleep deprivation and recovery protocols\",\n      \"pmids\": [\"10632591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream transcriptional targets mediating sleep phenotypes unknown\",\n        \"Brain region-specific versus systemic DBP contributions not dissected\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that CLOCK binds E-box elements in Dbp introns and that Clock mutation abolishes rhythmic Dbp transcription defined the upstream molecular mechanism placing Dbp as a direct first-order target of the CLOCK–BMAL1 heterodimer, while DBP feeds forward onto Per1 cooperatively with CLOCK–BMAL1.\",\n      \"evidence\": \"Clock-mutant mouse Dbp mRNA analysis, EMSA with E-box probes, Per1 promoter cotransfection assays\",\n      \"pmids\": [\"10733528\", \"10848603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Chromatin context of E-box activation not characterized\",\n        \"Quantitative contribution of DBP to Per1 amplitude versus direct CLOCK–BMAL1 drive unclear\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Comprehensive ChIP analysis revealed that BMAL1–CLOCK binding at Dbp E-boxes drives daily chromatin transitions between permissive euchromatin (H3K9ac, H3K4me3) and repressive heterochromatin (H3K9me2, HP1α), providing the first genome-locus-specific model of how circadian transcription factors remodel chromatin.\",\n      \"evidence\": \"Time-resolved ChIP for BMAL1, CLOCK, H3K9ac, H3K4me3, H3K9me2, HP1α at Dbp locus; E-box mutant reporter analysis\",\n      \"pmids\": [\"16474407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of histone methyltransferases/demethylases mediating these transitions unknown\",\n        \"Whether similar chromatin cycling occurs at all CLOCK–BMAL1 targets not established\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Triple PAR bZIP knockout (Dbp/Tef/Hlf−/−) demonstrated that these factors collectively govern xenobiotic detoxification gene programs, with compound loss causing xenobiotic hypersensitivity, premature aging, and death—resolving the long-standing question of functional redundancy among PAR bZIP members.\",\n      \"evidence\": \"Triple-KO mouse generation, transcriptome profiling of liver/kidney, xenobiotic challenge survival experiments\",\n      \"pmids\": [\"16814730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Individual contributions of DBP, TEF, and HLF not separable in triple-KO\",\n        \"Non-hepatic detoxification roles not examined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Cell-autonomous gain- and loss-of-function experiments showed DBP and its D-box antagonist E4BP4 are critical determinants of circadian period at the single-cell level, and identification of Kiss1 as a direct DBP target in the AVPV linked the circadian clock to the preovulatory GnRH/LH surge.\",\n      \"evidence\": \"siRNA/overexpression of DBP in Rat-1 fibroblasts with bioluminescent reporters; Kiss1 promoter D-box reporter assays and AVPV in situ hybridization\",\n      \"pmids\": [\"21635892\", \"21458520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo reproductive phenotype of Dbp-null females not reported\",\n        \"Whether DBP's period-setting role depends on its transcriptional targets or direct protein interactions unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Live-cell imaging of BMAL1 at Dbp locus arrays revealed that BMAL1–CLOCK act as 'Kamikaze activators' requiring proteasome-dependent rapid turnover to sustain transcriptional bursting, fundamentally revising the model of how circadian transcription factors activate target genes.\",\n      \"evidence\": \"Fluorescent BMAL1 live imaging at tandem Dbp repeat arrays, proteasome inhibition (MG132), single-copy Dbp-luciferase burst analysis\",\n      \"pmids\": [\"22981862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Ubiquitin ligase(s) targeting BMAL1–CLOCK at Dbp not identified\",\n        \"Whether Kamikaze mechanism generalizes to all circadian target promoters not tested\",\n        \"Relationship between burst frequency and chromatin state transitions unexplored\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Outstanding questions include the identity of the E3 ligase(s) that mediate BMAL1–CLOCK turnover at the Dbp locus, the brain region–specific transcriptional targets through which DBP controls sleep architecture and seizure susceptibility, and the individual versus redundant contributions of DBP relative to TEF and HLF at specific promoters in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of DBP–D-box DNA complex available\",\n        \"Post-transcriptional mechanisms restricting DBP protein to specific tissues not characterized\",\n        \"Genome-wide direct target map (ChIP-seq for DBP) in vivo not published in the timeline\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 5, 9, 10, 19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 5, 9, 10, 16, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009909396\", \"supporting_discovery_ids\": [1, 8, 11, 12, 15, 18, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 5, 10, 15, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 9, 13, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ARNTL\",\n      \"CLOCK\",\n      \"TEF\",\n      \"HLF\",\n      \"NFIL3\",\n      \"ESR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}